Top compounds associated with response to LGALS1


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.17 3e-07
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA PX-12 CTRPv2 pan-cancer AAC -0.16 3e-07
mRNA lapatinib CCLE pan-cancer AAC -0.24 6e-07
mRNA decitabine CTRPv2 pan-cancer AAC -0.15 9e-07
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.16 1e-06
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.17 1e-06
Download CSV